Treatment of Acute Ischemic Stroke With CATCHVIEW Stent Retriever in Comparison to SOLITAIRE 2/FR
Withdrawn · NCT03754296
Conditions: Acute Ischemic Stroke
At a glance
- Research payments reported, 2025
- $9,677
- U.S. investigators named
- 0
- Sites paid
- 0
About the trial
- Sponsor
- Balt Extrusion
- Tested
- CATCHVIEW (device)
- Dates
- Started 2018-12; completion 2020-03
- Results posted
- Not yet
The TRUST study is a non-interventional, prospective, multicenter, international, single arm and non-inferiority study. It is designed to evaluate the efficacy and safety of mechanical thrombectomy of the CATCHVIEW device compared to SOLITAIRE 2/FR based on an objective performance criterion (OPC) defined with available and published clinical evidence gathered through the Solitaire clinical trials in the arterial revascularization of patients with acute ischemic stroke.
From ClinicalTrials.gov, last updated 2020-01-09. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Balt USA, LLC reported $9,677 in research payments for this study in 2025 (6 payments).
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
Sites paid to run it
- $9,677
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.